{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"14.21","value":"91.01"},{"groupId":"OG001","spread":"7.98","value":"95.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"94"},{"groupId":"OG001","value":"12"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.37","value":"90.97"},{"groupId":"OG001","spread":"9.44","value":"93.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"88"},{"groupId":"OG001","value":"10"}],"units":"Participants"}],"title":"1 year"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.55","value":"93.06"},{"groupId":"OG001","spread":"8.69","value":"93.63"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"89"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"title":"2 years"}],"denoms":[{"counts":[{"groupId":"OG000","value":"100"},{"groupId":"OG001","value":"15"}],"units":"Participants"}],"description":"The EPIC 26 assessment scores each of 5 domains on a scale of 1-100 where higher scores indicate higher satisfaction. Questionnaires will be performed prior to treatment, and one and two years after completion of treatment.","dispersionType":"Standard Deviation","groups":[{"description":"Patients undergo 5 fractions of moderate dose SBRT with SIB every other day for 10 days following urethral-sparing IMRT planning.\n\nSBRT: 8.0Gy escalated dose\n\nRadiation Therapy Treatment Planning and Simulation: Undergo urethral-sparing IMRT planning\n\nSBRT: Undergo moderate dose SBRT with SIB","id":"OG000","title":"Arm A (Moderate Dose SBRT With SIB)"},{"description":"Patients undergo 5 fractions of uniform dose SBRT every other day for 10 days following urethral-sparing IMRT planning.\n\nSBRT: 7.5Gy conventional dose\n\nRadiation Therapy Treatment Planning and Simulation: Undergo urethral-sparing IMRT planning\n\nSBRT: Undergo uniform dose SBRT","id":"OG001","title":"Arm B (Uniform Dose SBRT)"}],"paramType":"MEAN","populationDescription":"Some participants did not complete survey at all time points.","reportingStatus":"POSTED","timeFrame":"at Baseline, 1 year, and 2 years","title":"Change in Expanded Prostate Cancer Index Composite (EPIC) 26 Quality of Life Assessment: Hormonal Sub-Domain","type":"SECONDARY","unitOfMeasure":"score on a scale"}